These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10998755)

  • 1. Insulin resistance and changes in the blood coagulation-fibrinolysis system after a glucose clamp technique in patients with type 2 diabetes mellitus.
    Takanashi K; Inukai T
    J Med; 2000; 31(1-2):45-62. PubMed ID: 10998755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
    Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans.
    Stegenga ME; van der Crabben SN; Levi M; de Vos AF; Tanck MW; Sauerwein HP; van der Poll T
    Diabetes; 2006 Jun; 55(6):1807-12. PubMed ID: 16731846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between plasminogen activator inhibitor-1 and insulin resistance in newly diagnosed type 2 diabetes mellitus.
    Gough SC; Rice PJ; McCormack L; Chapman C; Grant PJ
    Diabet Med; 1993; 10(7):638-42. PubMed ID: 8403825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of an early decline in baseline plasma glucose concentration after acute insulin elevation during euglycemic hyperinsulinemic clamp in patients with type 2 diabetes mellitus.
    Wasada T; Kuroki H; Arii H; Sato A; Katsumori K; Saito S; Iwamoto Y
    Endocr J; 2000 Jun; 47(3):309-16. PubMed ID: 11036875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin action and fibrinolysis influenced by vitamin E in obese Type 2 diabetes mellitus.
    Skrha J; Sindelka G; Kvasnicka J; Hilgertová J
    Diabetes Res Clin Pract; 1999 Apr; 44(1):27-33. PubMed ID: 10414937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired fibrinolysis and insulin resistance in patients with hypertension.
    Jeng JR; Sheu WH; Jeng CY; Huang SH; Shieh SM
    Am J Hypertens; 1996 May; 9(5):484-90. PubMed ID: 8735180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ratio of leptin to adiponectin can be used as an index of insulin resistance.
    Oda N; Imamura S; Fujita T; Uchida Y; Inagaki K; Kakizawa H; Hayakawa N; Suzuki A; Takeda J; Horikawa Y; Itoh M
    Metabolism; 2008 Feb; 57(2):268-73. PubMed ID: 18191059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas.
    Hoshino M; Haraguchi Y; Hirasawa H; Sakai M; Saegusa H; Hayashi K; Horita N; Ohsawa H
    Crit Care; 2001; 5(2):88-99. PubMed ID: 11299067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals: role of adipose tissue.
    Targher G; Bonadonna RC; Alberiche M; Zenere MB; Muggeo M; Bonora E
    Diabetes Care; 2001 Nov; 24(11):1961-6. PubMed ID: 11679465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects.
    Al-Hamodi Z; Ismail IS; Saif-Ali R; Ahmed KA; Muniandy S
    Cardiovasc Diabetol; 2011 Mar; 10():23. PubMed ID: 21414238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different metabolic correlations of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 in non-obese type 2 diabetic patients.
    Kitagawa N; Yano Y; Gabazza EC; Bruno NE; Araki R; Matsumoto K; Katsuki A; Hori Y; Nakatani K; Taguchi O; Sumida Y; Suzuki K; Adachi Y
    Diabetes Res Clin Pract; 2006 Aug; 73(2):150-7. PubMed ID: 16458385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass.
    Fischer S; Hanefeld M; Haffner SM; Fusch C; Schwanebeck U; Köhler C; Fücker K; Julius U
    Acta Diabetol; 2002 Sep; 39(3):105-10. PubMed ID: 12357293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individuals.
    Temelkova-Kurktschiev T; Koehler C; Schaper F; Henkel E; Hahnefeld A; Fuecker K; Siegert G; Hanefeld M
    Diabetologia; 1998 Jun; 41(6):706-12. PubMed ID: 9662054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between soluble thrombomodulin in plasma and coagulation or fibrinolysis in type 2 diabetes.
    Aso Y; Fujiwara Y; Tayama K; Takebayashi K; Inukai T; Takemura Y
    Clin Chim Acta; 2000 Nov; 301(1-2):135-45. PubMed ID: 11020468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of chronic mercury poisoning on blood coagulation and fibrinolysis systems].
    Song YG
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Dec; 23(6):405-7. PubMed ID: 16405768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of the renal threshold for glucose is associated with insulin resistance and higher glycated hemoglobin levels.
    Hieshima K; Sugiyama S; Yoshida A; Kurinami N; Suzuki T; Ijima H; Miyamoto F; Kajiwara K; Jinnouchi K; Jinnouchi T; Jinnouchi H
    J Diabetes Investig; 2020 May; 11(3):617-625. PubMed ID: 31770476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HbA1C and serum fructosamine in diabetic patients: relationship to age, clotting and fibrinolysis parameters and urinary microalbumin excretion.
    Van Wersch JW; Westerhuis LW; Venekamp WJ
    Clin Chim Acta; 1991 Sep; 201(1-2):99-104. PubMed ID: 1790631
    [No Abstract]   [Full Text] [Related]  

  • 20. No direct link between albumin excretion rate and insulin resistance--a study in type 1 diabetes patients with mild nephropathy.
    Svensson M; Eriksson JW
    Horm Metab Res; 2002 May; 34(5):254-9. PubMed ID: 12063639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.